Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 7

1.

Pharmacokinetics of ethambutol in children and adults with tuberculosis.

Zhu M, Burman WJ, Starke JR, Stambaugh JJ, Steiner P, Bulpitt AE, Ashkin D, Auclair B, Berning SE, Jelliffe RW, Jaresko GS, Peloquin CA.

Int J Tuberc Lung Dis. 2004 Nov;8(11):1360-7.

PMID:
15581206
2.

Population pharmacokinetics of ethionamide in patients with tuberculosis.

Zhu M, Namdar R, Stambaugh JJ, Starke JR, Bulpitt AE, Berning SE, Peloquin CA.

Tuberculosis (Edinb). 2002;82(2-3):91-6.

PMID:
12356460
3.

Ofloxacin population pharmacokinetics in patients with tuberculosis.

Stambaugh JJ, Berning SE, Bulpitt AE, Hollender ES, Narita M, Ashkin D, Peloquin CA.

Int J Tuberc Lung Dis. 2002 Jun;6(6):503-9.

PMID:
12068983
4.

Population pharmacokinetic modeling of pyrazinamide in children and adults with tuberculosis.

Zhu M, Starke JR, Burman WJ, Steiner P, Stambaugh JJ, Ashkin D, Bulpitt AE, Berning SE, Peloquin CA.

Pharmacotherapy. 2002 Jun;22(6):686-95.

PMID:
12066959
5.

Pharmacokinetics of ethambutol under fasting conditions, with food, and with antacids.

Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, Childs JM, Nix DE.

Antimicrob Agents Chemother. 1999 Mar;43(3):568-72.

6.

Pharmacokinetics of pyrazinamide under fasting conditions, with food, and with antacids.

Peloquin CA, Bulpitt AE, Jaresko GS, Jelliffe RW, James GT, Nix DE.

Pharmacotherapy. 1998 Nov-Dec;18(6):1205-11.

PMID:
9855317
7.

Population pharmacokinetic modeling of isoniazid, rifampin, and pyrazinamide.

Peloquin CA, Jaresko GS, Yong CL, Keung AC, Bulpitt AE, Jelliffe RW.

Antimicrob Agents Chemother. 1997 Dec;41(12):2670-9.

Supplemental Content

Loading ...
Support Center